Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
0.131
-0.009 (-6.16%)
Nov 15, 2024, 2:16 PM EST - Market open
TNXP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 11.29 | 7.77 | - | - | - | - | |
| Cost of Revenue | 8.95 | 4.74 | - | - | - | - | |
| Gross Profit | 2.34 | 3.03 | - | - | - | - | |
| Selling, General & Admin | 36.14 | 34.75 | 30.22 | 23.47 | 14.35 | 10.64 | |
| Research & Development | 48.8 | 86.66 | 81.88 | 68.84 | 36.16 | 18.19 | |
| Operating Expenses | 84.94 | 121.41 | 112.09 | 92.31 | 50.51 | 28.83 | |
| Operating Income | -82.59 | -118.38 | -112.09 | -92.31 | -50.51 | -28.83 | |
| Interest & Investment Income | - | - | - | 0.03 | 0.05 | 0.21 | |
| Other Non Operating Income (Expenses) | 4.63 | 1.72 | 1.87 | - | - | - | |
| Pretax Income | -135.25 | -116.66 | -110.22 | -92.29 | -50.46 | -28.62 | |
| Net Income | -135.25 | -116.66 | -110.22 | -92.29 | -50.46 | -28.62 | |
| Preferred Dividends & Other Adjustments | - | - | 6.66 | - | 1.71 | 2.47 | |
| Net Income to Common | -135.25 | -116.66 | -116.88 | -92.29 | -52.17 | -31.09 | |
| Shares Outstanding (Basic) | 17 | 1 | 0 | 0 | 0 | - | |
| Shares Outstanding (Diluted) | 17 | 1 | 0 | 0 | 0 | - | |
| Shares Change (YoY) | 4773.77% | 191.70% | 220.61% | 285.23% | - | - | |
| EPS (Basic) | -7.77 | -219.09 | -640.26 | -1620.86 | -3530.04 | - | |
| EPS (Diluted) | -7.77 | -219.09 | -640.26 | -1620.86 | -3530.04 | - | |
| Free Cash Flow | - | -109.9 | -146.2 | -110.86 | -57.13 | -26.7 | |
| Free Cash Flow Per Share | - | -206.39 | -800.90 | -1947.13 | -3865.36 | - | |
| Gross Margin | 20.74% | 38.97% | - | - | - | - | |
| Operating Margin | -731.49% | -1523.94% | - | - | - | - | |
| Profit Margin | -1197.86% | -1501.78% | - | - | - | - | |
| Free Cash Flow Margin | - | -1414.75% | - | - | - | - | |
| EBITDA | -78.43 | -114.09 | -110.84 | -92.26 | -50.48 | -28.8 | |
| D&A For EBITDA | 4.16 | 4.29 | 1.25 | 0.05 | 0.03 | 0.03 | |
| EBIT | -82.59 | -118.38 | -112.09 | -92.31 | -50.51 | -28.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.